Drugs are a frequently cited cause of dementia. There is a paucity of
data regarding the incidence of drug-induced dementia, but it has been
estimated that over 10% of patients attending memory clinics have iat
rogenic disease. Drugs may impair cognition indirectly via metabolic e
ffects, such as hypoglycaemia, by alterations of immunological factors
within the CNS, and by actions that interfere with synaptic transmiss
ion. Classes of drugs most frequently responsible are the benzodiazepi
nes, antihypertensives and drugs with anticholinergic properties. Each
of these classes is likely to produce a different pattern of neuropsy
chological deficits. Prevention of drug-induced dementia will be aided
by: (i) minimising the number of drugs prescribed; (ii) using shorter
-acting preparations; (iii) avoiding agents that cross the blood-brain
barrier where possible; (iv) evaluating renal and hepatic function re
gularly; and (v) briefly assessing cognitive function before treatment
.